| Programmed cell death ligand-1 (PD-L1) and CD8 expression profiling identify an immunologic subtype of pancreatic ductal adenocarcinomas with favorable survival L Danilova, WJ Ho, Q Zhu, T Vithayathil, A De Jesus-Acosta, NS Azad, ... Cancer immunology research 7 (6), 886-895, 2019 | 214 | 2019 |
| Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity. WJ Ho, Q Zhu, J Durham, A Popovic, S Xavier, J Leatherman, A Mohan, ... Nature cancer 2 (9), 891-903, 2021 | 186 | 2021 |
| Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade S Berry, NA Giraldo, BF Green, TR Cottrell, JE Stein, EL Engle, H Xu, ... Science 372 (6547), eaba2609, 2021 | 174 | 2021 |
| Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma PTM Gani F, Nagarajan N, Kim Y, Zhu Q, Luan L, Bhaijjee F, Anders RA Ann Surg Oncol 23 (8), 2610-7, 2013 | 160* | 2013 |
| Axon guidance molecules promote perineural invasion and metastasis of orthotopic pancreatic tumors in mice NR Jurcak, AA Rucki, S Muth, E Thompson, R Sharma, D Ding, Q Zhu, ... Gastroenterology 157 (3), 838-850. e6, 2019 | 144 | 2019 |
| Characterization of the immune microenvironment in hepatocellular carcinoma M Yarchoan, D Xing, L Luan, H Xu, RB Sharma, A Popovic, TM Pawlik, ... Clinical Cancer Research 23 (23), 7333-7339, 2017 | 142 | 2017 |
| The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma J Ai, Q Tang, Y Wu, Y Xu, T Feng, R Zhou, Y Chen, X Gao, Q Zhu, X Yue, ... Journal of the National Cancer Institute 103 (22), 1696-1712, 2011 | 103 | 2011 |
| Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/E2F transcription factor 1–dependent apoptotic … HX Sun, Y Xu, XR Yang, WM Wang, H Bai, RY Shi, SK Nayar, ... Hepatology 57 (3), 1088-1097, 2013 | 102 | 2013 |
| Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy K Li, JA Tandurella, J Gai, Q Zhu, SJ Lim, DL Thomas, T Xia, G Mo, ... Cancer Cell 40 (11), 1374-1391. e7, 2022 | 94 | 2022 |
| Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma Y Xu, V Chenna, C Hu, HX Sun, M Khan, H Bai, XR Yang, QF Zhu, YF Sun, ... Clinical Cancer Research 18 (5), 1291-1302, 2012 | 83 | 2012 |
| Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity WJ Ho, Q Zhu, J Durham, A Popovic, S Xavier, J Leatherman, A Mohan, ... Nature Cancer 2 (9), 891-903, 2021 | 76 | 2021 |
| Pharmacological activation of myosin II paralogs to correct cell mechanics defects A Surcel, WP Ng, H West-Foyle, Q Zhu, Y Ren, LB Avery, AK Krenc, ... Proceedings of the National Academy of Sciences 112 (5), 1428-1433, 2015 | 76 | 2015 |
| A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human … B Hu, D Sun, C Sun, YF Sun, HX Sun, QF Zhu, XR Yang, YB Gao, ... Biochemical and biophysical research communications 468 (4), 525-532, 2015 | 73 | 2015 |
| Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers M Yarchoan, L Cope, AN Ruggieri, RA Anders, AM Noonan, LW Goff, ... The Journal of Clinical Investigation 131 (24), 2021 | 72 | 2021 |
| Targeting mechanoresponsive proteins in pancreatic cancer: 4-hydroxyacetophenone blocks dissemination and invasion by activating MYH14 A Surcel, ES Schiffhauer, DG Thomas, Q Zhu, K DiNapoli, M Herbig, ... Biophysical Journal 116 (3), 260a, 2019 | 71 | 2019 |
| A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer M Yarchoan, CY Huang, Q Zhu, AK Ferguson, JN Durham, RA Anders, ... Cancer medicine 9 (4), 1485-1494, 2020 | 63 | 2020 |
| Histopathological and immunophenotypic features of ipilimumab‐associated colitis compared to ulcerative colitis BL Adler, MK Pezhouh, A Kim, L Luan, Q Zhu, F Gani, M Yarchoan, ... Journal of internal medicine 283 (6), 568-577, 2018 | 54 | 2018 |
| Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence S Zhang, L Yuan, L Danilova, G Mo, Q Zhu, A Deshpande, ATF Bell, ... Genome medicine 15 (1), 72, 2023 | 53 | 2023 |
| Vaccine-induced intratumoral lymphoid aggregates correlate with survival following treatment with a neoadjuvant and adjuvant vaccine in patients with resectable pancreatic … L Zheng, D Ding, BH Edil, C Judkins, JN Durham, DL Thomas, KM Bever, ... Clinical Cancer Research 27 (5), 1278-1286, 2021 | 52 | 2021 |
| Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 KN Smith, NJ Llosa, TR Cottrell, N Siegel, H Fan, P Suri, HY Chan, H Guo, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 48 | 2019 |
